[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578418":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":62,"centralContacts":67,"locations":72,"responsibleParty":88,"collaborators":90,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":58,"eligibilityCriteria":100,"healthyVolunteers":101,"sex":102,"minAge":103,"maxAge":58,"enrollmentInfo":104,"targetDuration":58,"studyType":107,"phases":108,"briefSummary":110,"conditions":111,"keywords":58,"overallStatus":113,"whyStopped":58,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":123},{"fullName":5,"class":6},"Fred Hutchinson Cancer Center","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm I (iCanQuit application)","EXPERIMENTAL","Participants receive access to the iCanQuit smartphone application for 12 months and complete personalized quit plans with education regarding managing urges, motivation, and relapse prevention, on-demand help with tracking of daily cigarette consumption, and monitoring of urges passed without smoking.",[13,14,15],"Device: iCanQuit Smartphone App Smoking Cessation Program","Other: Survey Administration","Other: Interview",{"label":17,"type":10,"description":18,"interventionNames":19},"Arm II (iCanQuit application and NRT)","Participants receive access to the iCanQuit smartphone application for 12 months and complete personalized quit plans with education regarding managing urges, motivation, and relapse prevention, on-demand help with tracking of daily cigarette consumption, and monitoring of urges passed without smoking. Participants also receive NRT patch(es) and gum to use per the usage instructions tailored to the participants' baseline smoking levels. In addition, participants receive daily push notifications with NRT dosage and refill reminders for 12 months.",[13,20,21,22,14,15],"Drug: Nicotine Gum","Drug: Nicotine Patch","Drug: Nicotine Lozenge",[24,31,39,47,54,59],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"DEVICE","iCanQuit Smartphone App Smoking Cessation Program","Receive access to iCanQuit app, with daily push notifications",[9,17],[30],"iCanQuit",{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"DRUG","Nicotine Gum","Receive nicotine replacement therapy gum",[17],[37,38],"Nicorette","Nicotine Polacrilex gum",{"type":32,"name":40,"description":41,"armGroupLabels":42,"otherNames":43},"Nicotine Patch","Receive nicotine replacement therapy patch(es)",[17],[44,45,46],"NicoDerm CQ","Nicotine Skin Patch","Nicotine Transdermal Patch",{"type":32,"name":48,"description":49,"armGroupLabels":50,"otherNames":51},"Nicotine Lozenge","Receive nicotine replacement therapy lozenge(s)",[17],[37,52,53],"mini lozenge","Nicotine Polacrilex lozenge",{"type":6,"name":55,"description":56,"armGroupLabels":57,"otherNames":58},"Survey Administration","Ancillary studies",[9,17],null,{"type":6,"name":60,"description":56,"armGroupLabels":61,"otherNames":58},"Interview",[9,17],[63],{"name":64,"affiliation":65,"role":66},"Jonathan Bricker, PhD","Fred Hutch\u002FUniversity of Washington Cancer Consortium","PRINCIPAL_INVESTIGATOR",[68],{"name":64,"role":69,"phone":70,"phoneExt":58,"email":71},"CONTACT","206-667-5074","jbricker@fredhutch.org",[73],{"facility":65,"status":58,"city":74,"state":75,"zip":76,"country":77,"countryCode":78,"cosmosGeoPoint":79,"geoPoint":84,"contacts":85},"Seattle","Washington","98109","United States","US",{"type":80,"coordinates":81},"Point",[82,83],-122.33207,47.60621,{"lat":83,"lon":82},[86,87],{"name":64,"role":69,"phone":70,"phoneExt":58,"email":71},{"name":64,"role":66,"phone":58,"phoneExt":58,"email":58},{"type":89,"investigatorFullName":58,"investigatorTitle":58,"investigatorAffiliation":58,"oldNameTitle":58,"oldOrganization":58},"SPONSOR",[91],{"name":92,"class":93},"National Cancer Institute (NCI)","NIH","100578418","phase-3-icanquit-smoking-cessation-among-hispanic-adults-100578418",false,"NCT06811038","iCanQuit Smoking Cessation Among Hispanic Adults","Providing Nicotine Replacement Therapy to Enhance the Efficacy of a Smoking Cessation Smartphone App for Hispanic Adults","Inclusion Criteria:\n\n* Self-identify as Hispanic ethnicity\n* Age 18 and older\n* Smoking at least one cigarette per day in the past 30 days\n* Want to quit smoking within 30 days\n* Interest in learning skills to quit smoking\n* Willing to be randomly assigned\n* United States (US) or Puerto Rico (PR) residency for the next twelve months\n* Have daily access to their own Android or iPhone smartphone\n* Ability to download a smartphone application (app)\n* Proficiency in English or Spanish\n* Not currently (i.e., within past 30 days) using other smoking cessation interventions\n* Willing to consider using NRT\n* No previous use of iCanQuit\n* No household or family member participating\n* Willingness to complete follow-up assessments at the 3-, 6-, and 12-month follow-ups\n* Providing email, phone number(s), and mailing address\n\nExclusion Criteria:\n\n* NRT CONTRAINDICATION: Heart attack in the last 2 months\n* NRT CONTRAINDICATION: Stroke in the last 6 months\n* NRT CONTRAINDICATION: Diagnosed arrhythmia or tachycardia\n* NRT CONTRAINDICATION: Uncontrolled hypertension\n* NRT CONTRAINDICATION: Currently using warfarin\n* NRT CONTRAINDICATION: Pregnant or breastfeeding, or plans to become pregnant during the next 6 months",true,"ALL","18 Years",{"count":105,"type":106},854,"ESTIMATED","INTERVENTIONAL",[109],"PHASE3","This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with personalized quit plans. Nicotine replacement therapy works by giving small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking without any of the other harmful chemicals found in tobacco products.",[112],"Cigarette Smoking-Related Carcinoma","NOT_YET_RECRUITING","2026-06-08",{"date":116,"type":117},"2026-06-09","ACTUAL",{"date":119,"type":106},"2026-08-15",{"date":121,"type":106},"2030-07-01",{"name":5,"class":6},1]